Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The care team gathers supporting records
The question of whether Mounjaro is a GLP-1 receptor agonist is nuanced
Transdermal-specific considerations for patches would include: Local skin reactions (erythema, itching, irritation at application site) Contact dermatitis from adhesive components or penetration enhancers Skin integrity concerns requiring regular site rotation Patient safety advice for anyone using GLP-1 therapy includes: Report persistent severe abdominal pain (potential pancreatitis) Monitor for signs of gallbladder problems (right upper quadrant pain, particularly after meals) Maintain adequate hydration, especially if experiencing vomiting or diarrhoea Contact your GP if side effects are severe, persistent, or concerning Report suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk) Regarding pregnancy and breastfeeding, advice varies by product
GLP-1 medications affect people differently
Dose escalation speed and individual receptor sensitivity appear to influence the side effect burden more than which specific drug is chosen
US$ 27.68
US$ 20.99
US$ 23.66
US$ 28.02
